Movement Alert｜Xylem Intraday Rise 5.01%, shares rebound after another target price cut

Market Focus11-03

On November 3, Xylem rose 5.01% in Regular Trading, trading at $97.05 per share, with turnover of $128 million.

The most recent catalyst in public information was a target-price cut by Rothschild & Co Redburn to $129 from $165, even as the stock rebounded intraday after a sharp post-earnings reset.

Background context shows selling-side estimates have been reduced following the company’s late-October results and outlook cut. Xylem reported third-quarter adjusted EPS of $1.44 on revenue of $2.20 billion, both slightly below consensus, and lowered full-year adjusted EPS guidance to $5.40-$5.45 from $5.55-$5.70 while guiding revenue to about $8.95 billion versus expectations near $9.19 billion. After that update, Barclays downgraded the stock to Equalweight with a $104 target, and JPMorgan cut it to Underweight with a $90 target, underscoring a broader reassessment of growth and margin expectations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment